Table 2.
All FSHD1 patients (n = 52) | Healthy subjects (n = 29) | FSHD1 with focal fibrosis (n = 13) | FSHD1 without focal fibrosis (n = 39) | |
---|---|---|---|---|
EF (%) | 63 ± 5 | 64 ± 4 | 62 ± 4 | 63 ± 5 |
EDV (mL) | 126 ± 21 | 120 ± 22 | 127 ± 29 | 125 ± 17 |
ESV (mL) | 48 ± 11 | 43 ± 11 | 50 ± 13 | 48 ± 11 |
SV (mL) | 78 ± 15 | 77 ± 13 | 77 ± 20 | 78 ± 12 |
EDVi (mL/cm) | 0.69 ± 0.10 | 0.73 ± 0.13 | 0.69 ± 0.13 | 0.69 ± 0.09 |
LVMi (g/cm) | 0.55 ± 0.12 | 0.58 ± 0.08 | 0.61 ± 0.13* | 0.53 ± 0.11 |
EF = ejection fraction; EDV = end-diastolic volume; ESV = end-systolic volume; SV = stroke volume; EDVi = end-diastolic volume index; LVMi = left ventricular mass index. * p < 0.05 (healthy subjects compared to FSHD1)